Use of generic medicines by the Brazilian population: an evaluation of PNAUM 2014

Bertoldi, Andréa Dâmaso; Arrais, Paulo Sergio Dourado; Tavares, Noemia Urruth Leão; Ramos, Luiz Roberto; Luiza, Vera Lucia; Mengue, Sotero Serrate; Dal-Pizzol, Tatiane da Silva; Farias, Mareni Rocha; Oliveira, Maria Auxiliadora.
Rev. saúde pública ; 50(supl.2): 11s, 2016. tab, graf
Artigo em Inglês | LILACS | ID: biblio-830783

Documentos relacionados

  1. Use of generic medicines by the Brazilian population: an evaluation of PNAUM 2014.
  2. Willingness to pay brand premiums for generic medicines in Kenya: A bidding game experiment.
  3. Generic drug prescribing in primary care: A nationwide analysis.
  4. Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study.
  5. Inequalities in the profile of using dental services in Brazil.
  6. Generic Medicinal Products in Immunosuppressive Therapy-Should It be a Challenge for Therapeutic Drug Monitoring?
  7. Bioequivalence trials for the approval of generic drugs in Saudi Arabia: a descriptive analysis of design aspects.
  8. State Laws and Generic Substitution in the Year After New Generic Competition.
  9. [Recent changes and continuity of technological and economic dependency in the pharmaceutical industry in Brazil].
  10. The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies-An Empirical Study Based on the Difference-in-Differences Model.